ANYSELaboratory Analytical InstrumentsFiscal year ends October 31
AGILENT TECHNOLOGIES, INC.
Financials through Q3 FY2026, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 1, 2026
$169.90−3.07 (-1.77%)
Close on Oct 19, 2026
- Market cap
- $48.08B
- P/E (TTM)
- 33.5
- Dividend yield
- 0.58%
AGILENT TECHNOLOGIES, INC. revenue by segment
By business segment
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $2.91B | $2.75B | $2.66B | $1.45B | $1.36B | $1.18B | $1.84B | $1.70B | $1.53B | $1.42B | 41.9% | +5.9% |
| Life Sciences and Diagnostics Markets | $2.73B | $2.47B | $2.78B | – | – | – | – | – | – | – | 39.2% | +10.5% |
| Applied Markets | $1.31B | $1.30B | $1.40B | – | – | – | – | – | – | – | 18.9% | +1.3% |
| Segment Total | – | – | – | $6.85B | $6.32B | $5.34B | $5.16B | $4.91B | $4.47B | $4.20B | – | – |
| Diagnostics and Genomics | – | $1.65B | $1.76B | $1.77B | $1.30B | $1.05B | $1.02B | $943.00M | $860.00M | $790.00M | – | – |
| Life Sciences and Applied Markets | – | $3.22B | $3.51B | $3.63B | $3.66B | $3.12B | $2.30B | $2.27B | $2.08B | $1.99B | – | – |
| Operating income | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Agilent CrossLab | $946.00M | $925.00M | $839.00M | $370.00M | $323.00M | $272.00M | $475.00M | $388.00M | $336.00M | $316.00M | +2.3% |
| Life Sciences and Diagnostics Markets | $536.00M | $484.00M | $673.00M | – | – | – | – | – | – | – | +10.7% |
| Applied Markets | $301.00M | $312.00M | $363.00M | – | – | – | – | – | – | – | -3.5% |
| Segment Total | – | – | – | $1.86B | $1.61B | $1.26B | $1.20B | $1.10B | $973.00M | $859.00M | – |
| Diagnostics and Genomics | – | $320.00M | $363.00M | $390.00M | $273.00M | $192.00M | $185.00M | $173.00M | $167.00M | $131.00M | – |
| Life Sciences and Applied Markets | – | $877.00M | $1.05B | $1.10B | $1.02B | $792.00M | $542.00M | $543.00M | $470.00M | $412.00M | – |
By product or service
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Product | $4.94B | $4.67B | $5.05B | $5.19B | $4.76B | $3.99B | $3.88B | $3.75B | $3.40B | $3.21B | 71.2% | +5.8% |
| Non-Instrumentation and Other | $4.52B | $4.16B | $4.09B | $3.94B | $3.66B | $3.09B | $3.01B | – | – | – | 65.1% | +8.8% |
| Instrumentation | $2.43B | $2.35B | $2.74B | $2.91B | $2.66B | $2.25B | $2.15B | $2.03B | $1.86B | $1.79B | 34.9% | +3.1% |
| Services and Other | $2.00B | $1.84B | $1.78B | $1.66B | $1.56B | $1.35B | $1.29B | $1.17B | $1.08B | $989.00M | 28.8% | +9.0% |
| Analytical lab consumables [Member] | – | – | – | – | – | – | – | $618.00M | $540.00M | $510.00M | – | – |
| Informatics and other [Member] | – | – | – | – | – | – | – | $238.00M | $223.00M | $202.00M | – | – |
| Analytical Lab Services [Member] | – | – | – | – | – | – | – | $1.08B | $991.00M | $910.00M | – | – |
| Diagnostics and genomics solutions [Member] | – | – | – | – | – | – | – | $943.00M | $860.00M | $790.00M | – | – |
By region
| Revenue | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rest Of World | $3.38B | $3.05B | $3.04B | $2.96B | $2.89B | $2.50B | $2.53B | $2.49B | $2.26B | $2.11B | 48.7% | +11.0% |
| Americas | $2.81B | $2.57B | $2.73B | $2.68B | $2.40B | $1.97B | $1.86B | – | – | – | 40.4% | +9.1% |
| United States | $2.34B | $2.25B | $2.41B | $2.39B | $2.16B | $1.75B | $1.62B | $1.41B | $1.31B | $1.25B | 33.7% | +4.3% |
| Asia Pacific | $2.22B | $2.17B | $2.35B | $2.47B | $2.23B | $1.93B | $1.86B | – | – | – | 31.9% | +2.4% |
| Europe | $1.92B | $1.77B | $1.75B | $1.70B | $1.69B | $1.44B | $1.44B | – | – | – | 27.7% | +8.6% |
| China | $1.22B | $1.22B | $1.38B | $1.50B | $1.27B | $1.09B | $1.02B | $1.02B | $900.00M | $839.00M | 17.6% | +0.6% |
From the segment and revenue-disaggregation notes of Agilent Technologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.